New WHO Guideline on Testing of Counterfeit Medicines
Recommendation
28/29 January 2025
Generation, Monitoring & Compliance
The World Health Organization (WHO) has published a new guideline that describes the procedure for checking supposedly counterfeit or suspect medicines.
The WHO distinguishes three types of "Suspect Medicines":
- "Out of specification" medicines
- Unregistered/unlicensed medicines
- Medicines that have been deliberately falsified.
The present guideline deals mainly with the third category. It contains technical assistance for sampling, laboratory testing of supposedly falsified medicinal products and the corresponding reporting. Examples of this can be found in the appendix of the document for
- Analysis methods for package identification
- An information collection form
- Content of a SOP for testing counterfeit tablets
- Flowcharts for the review procedure (decision tree)
Please visit the WHO website for the new WHO guidance testing of "suspect" falsified medicines.
Related GMP News
31.07.2024Report on Trends in the Falsification of Medicines
11.06.2024Serialization - Version 21 of the Q&As on Safety Features
17.01.2024Ozempic Falsification also in the US
20.12.2023US Track & Trace Guidance on Verification Systems
07.12.2023Falsification of Ozempic Confirmed
18.10.2023Ozempic Falsifications: BfArM starts Investigation